Skip to content

Multimodal Analgesia Methods in Patients Undergoing IPACK Block in Knee Arthroplasty

Evaluation of Multimodal Analgesia Methods in Patients Who Underwent IPACK Block in Total Knee Arthroplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04213287
Enrollment
70
Registered
2019-12-30
Start date
2019-12-23
Completion date
2020-03-15
Last updated
2019-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IPACK Block Multimodal Analgesia, Postoperative NRS Scores

Brief summary

A comparison of two pain control methods - the combination of Adductor Canal Block (ACB)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)/ Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) - in patients undergoing total knee arthroplasty. dexketoprofen and paracetamol will be added to both groups and multimodal analgesia will be applied. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).

Detailed description

Postoperative pain after total knee arthroplasty is serious and difficult to management. Multimodal analgesia recommended for the pain management. For these reasons, we planned a study involving two multimodal analgesia regimens. Patients who will undergo total knee arthroplasty will receive preemptive oral analgesic (dexketofrofen) 1 hour before the operation. Surgery will be initiated after spinal anesthesia is applied to the patients. Two pain control methods - the combination of Adductor Canal Block (ACB)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)/ IPACK- will be applied at the end of the surgery. dexketoprofenand paracetamol will be added to both groups and multimodal analgesia will be applied. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).

Interventions

Drug: Dexketoprofen Trometamol oral tablet

OTHERspinal anesthesia

Drug: heavy bupivacaine 2,5 ml 0,5%

OTHERIPACK

Drug: bupivacaine 20 ml 0,025%

OTHERPAI

Drug: bupivacaine 30 ml 0,025%

OTHERAdductor canal block

Drug: bupivacaine 20 ml 0,025%

Sponsors

Ankara Diskapi Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Power analysis will be done after a pilot study. Number of patient may vary.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with osteoarthritis scheduled for a primary either partial or total knee arthroplasty with a participating surgeon * Age 18 to 80 years * Planned use of regional anesthesia * Ability to follow study protocol * Patients of participating surgeons

Exclusion criteria

* Hepatic or renal insufficiency * Younger than 18 years old and older than 80 * Patients undergoing general anesthesia * Allergy or intolerance to one of the study medications * BMI \> 40 * Diabetes * ASA of IV * Chronic gabapentin/pregabalin use (regular use for longer than 3 months) * Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine equivalent of \>5mg/day for one month)

Design outcomes

Primary

MeasureTime frameDescription
NRS Pain Scores24 hours post block administrationNRS Pain scores with ambulation 24 hours post block administration.All patients' postoperative pain numerical rating scale (NRS-numeric rating scale; 0 = absence of pain, 10 = unbearable pain) will be recorded in both groups.

Secondary

MeasureTime frameDescription
NRS at Rest and with movement24 hours on Post-Operative Day 1NRS at rest and with movement at different intervals. All patients' postoperative pain numerical rating scale (NRS-numeric rating scale; 0 = absence of pain, 10 = unbearable pain) will be recorded in both groups.
Patient Satisfaction with Pain Control using the likert scalePost-Operative 24 hoursSatisfaction with Pain control at different intervals. 1-5 (according to patient satisfaction)

Countries

Turkey (Türkiye)

Contacts

Primary Contactilkay MD Baran akkus, MD
ilkayb@hotmail.com0905323852642

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026